AI assistant
Prudential PLC — Regulatory Filings 2020
Feb 25, 2020
4668_rns_2020-02-25_4f15ad58-c447-4a72-a134-7cc0d484cc6b.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0222E
Prudential PLC
25 February 2020
NEWS RELEASE
25 February 2020
Prudential receives Third Point LLC letter
Prudential confirms that it has received a letter yesterday from Third Point LLC.
Prudential proactively engages with shareholders with regards to Group strategy and structure, and looks forward to commencing a dialogue with Third Point with regard to the views outlined in its letter.
Prudential will provide an update on the Group's performance and strategy at its full-year results on 11 March 2020.
Enquiries:
| Media | Investors/Analysts | ||
| Jonathan Oliver | +44 (0)20 3977 9500 | Patrick Bowes | +44 (0)20 3977 9702 |
| Tom Willetts | +44 (0)20 3977 9760 | William Elderkin | +44 (0)20 3977 9215 |
Notes to Editors:
About Prudential plc
Prudential plc is an Asia-led portfolio of businesses focused on structural growth markets. The business helps individuals to de-risk their lives and deal with their biggest financial concerns through life and health insurance, and retirement and asset management solutions. Prudential plc has 20 million customers and is listed on stock exchanges in London, Hong Kong, Singapore and New York. Prudential plc is not affiliated in any manner with Prudential Financial, Inc., a company whose principal place of business is in the United States of America, nor with the Prudential Assurance Company, a subsidiary of M&G plc, a company incorporated in the United Kingdom.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
MSCGLGDDSUDDGGU